Cart
sales@molnova.com
Rovazolac
CAS No. 1454288-88-0
Rovazolac( —— )
Catalog No. M33485 CAS No. 1454288-88-0
Rovazolac (ALX-101) is a liver x receptor (LXR) modulator used in the study of immune system disorders and atopic dermatitis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 102 | In Stock |
|
| 10MG | 164 | In Stock |
|
| 25MG | 330 | In Stock |
|
| 50MG | 498 | In Stock |
|
| 100MG | 759 | In Stock |
|
| 200MG | 1004 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRovazolac
-
NoteResearch use only, not for human use.
-
Brief DescriptionRovazolac (ALX-101) is a liver x receptor (LXR) modulator used in the study of immune system disorders and atopic dermatitis.
-
DescriptionRovazolac is a liver x receptor (LXR) modulator extracted from patent WO2013130892A1.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorLiver X Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1454288-88-0
-
Formula Weight452.45
-
Molecular FormulaC21H19F3N2O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?Ethanol : 10 mg/mL (22.10 mM; Ultrasonic)
-
SMILESCCOC(=O)Cn1nc(cc1-c1ccc(cc1)-c1cccc(c1)S(C)(=O)=O)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Mohan R. Preparation of substituted pyrazoles as liver X receptor (LXR) modulators useful for the treatment of dermal diseases, disorders and conditions. WO2013130892A1
molnova catalog
related products
-
Penetratin
Penetratin
-
Gerardianin D
The young shoots of Chamaecyparis obtusa.
-
Egg yolk phosphatidy...
Lecithins, egg can be used as an excipient. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs.
